2019
DOI: 10.2174/1573398x15666190117133311
|View full text |Cite
|
Sign up to set email alerts
|

The Innovations in Pulmonary Hypertension Pathophysiology and Treatment: What are our Options!

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 145 publications
0
1
0
Order By: Relevance
“…treatment, and risk stratification is imperative and can be lifesaving. Overall mortality is high, with sudden death being the initial symptom for about 25% of patients [3]. Pulmonary Embolism is Thrombolytic therapy can be either administered systemically or via Catheter Directed Interventions (CDI) [7].…”
mentioning
confidence: 99%
“…treatment, and risk stratification is imperative and can be lifesaving. Overall mortality is high, with sudden death being the initial symptom for about 25% of patients [3]. Pulmonary Embolism is Thrombolytic therapy can be either administered systemically or via Catheter Directed Interventions (CDI) [7].…”
mentioning
confidence: 99%